Previous Page  37 / 40 Next Page
Information
Show Menu
Previous Page 37 / 40 Next Page
Page Background

Maintenance low-dose chemotherapy in patients

with high-risk (HR) rhabdomyosarcoma (RMS): A

report from the European Paediatric Soft Tissue

Sarcoma Study Group (EpSSG)

Bisogno 2018